Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-2lccl Total loading time: 0 Render date: 2024-04-26T19:41:48.926Z Has data issue: false hasContentIssue false

Rufinamide

Published online by Cambridge University Press:  01 June 2018

Philip N. Patsalos  and
Erik K. St Louis
Philip N. Patsalos
Affiliation:
UCL Institute for Neurology
Erik K. St Louis
Affiliation:
Mayo Clinic
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
The Epilepsy Prescriber's Guide to Antiepileptic Drugs , pp. 266 - 273
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Suggested Reading

Arroyo, S. Rufinamide. Neurotherapeutics 2007; 4: 155–162.CrossRefGoogle ScholarPubMed
Cardot, JM, Lecaillon, JB, Czendlik, C, Godbillon, J. The influence of food on the disposition of the antiepileptic rufinamide in healthy volunteers. Biopharmacy and Drug Disposition 1998; 19: 259–262.3.0.CO;2-V>CrossRefGoogle ScholarPubMed
Coppola, G, Besag, F, Cusmai, R, Dulac, O, Kluger, G, Moavero, R, Nabbout, R, Nikanorova, M, Pisani, F, Verrotti, A, von Stulpnagel, C, Curatolo, P. Current role of rufinamide in the treatment of childhood epilepsy: literature review and treatment guidelines. European Journal of Paediatric Neurology 2014; 18: 685–690.CrossRefGoogle ScholarPubMed
Coppola, G, Zamponi, N, Kluger, G, Mueller, A, Anna Rita, M, Parisi, P, Isone, C, Santoro, E, Curatolo, P, Verrotti, A. Rufinamide for refractory focal seizures: an open-label, multicenter European study. Seizure 2013; 22: 33–36.CrossRefGoogle ScholarPubMed
Glauser, T, Kluger, G, Sachdeo, R, Krauss, G, Perdomo, C, Arroyo, S. Rufinamide for generalized seizures associated with Lennox–Gastaut syndrome. Neurology 2008; 70: 1950–1958.CrossRefGoogle ScholarPubMed
Mazzucchelli, I, Rapetti, M, Fattore, C, Franco, V, Gatti, G, Perucca, E. Development and validation of an HPLC-UV detection assay for the determination of rufinamide in human plasma and saliva. Analytical and Bioanalytical Chemistry 2011; 401: 1013–1021.CrossRefGoogle ScholarPubMed
Mourand, I, Crespel, A, Gelisse, P. Dramatic weight loss with rufinamide. Epilepsia 2013; 54: e5–e8.CrossRefGoogle ScholarPubMed
Olson, HE, Loddenkemper, T, Vendrame, M, Poduri, A, Takeoka, M, Bergin, AM, Libenson, MH, Duffy, FH, Rotenberg, A, Coulter, D, Bourgeois, BF, Kothare, SV. Rufinamide for the treatment of epileptic spasms. Epilepsy and Behavior 2011; 20: 344–348.CrossRefGoogle ScholarPubMed
Perucca, E, Cloyd, J, Critchley, D, Fuseau, E. Rufinamide: clinical pharmacokinetics and concentration–response relationships in patients with epilepsy. Epilepsia 2008; 49: 1123–1141.CrossRefGoogle ScholarPubMed
Stülpnagel, C von, Coppola, G, Striano, P, Müller, A, Staudt, M, Kluger, G. First long-term experience with the orphan drug rufinamide in children with myoclonic-astatic epilepsy (Doose syndrome). European Journal of Paediatric Neurology 2012; 16: 459–463.CrossRefGoogle Scholar
Vendrame, M, Loddenkemper, T, Gooty, VD, Takeoka, M, Rotenberg, A, Bergin, AM, Eksioglu, YZ, Poduri, A, Duffy, FH, Libenson, M, Bourgeois, BF, Kothare, SV. Experience with rufinamide in a pediatric population: a single center’s experience. Pediatric Neurology 2010; 43: 155–158.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×